Stock Events

Stock Events

Luye Pharma Group 

€0
0
+€0+0% Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

29MarExpected
Q4 2025
0.01
0.34
0.68
1.01
Expected EPS
0.009952760832
Actual EPS
0.009952760832

People Also Follow

This list is based on the watchlists of people on Stock Events who follow LUP.MU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
HUTCHMED (China) Limited
HCM
Mkt Cap2.78B
Hutchison China MediTech, operates in the same region and focuses on innovative biopharmaceuticals, directly competing in Luye Pharma's market segments.
Zai Lab Limited
ZLAB
Mkt Cap2.31B
Zai Lab Limited, focuses on developing and commercializing a diverse range of healthcare products, including those in oncology and autoimmune diseases, similar to Luye Pharma.
Sinovac Biotech
SVA
Mkt Cap642.44M
Sinovac Biotech, although primarily known for vaccines, competes in the broader biopharmaceutical market in China, impacting Luye Pharma's market share.
GSK
GSK
Mkt Cap113.29B
GlaxoSmithKline, a global pharmaceutical giant with a significant presence in China, offers products that compete across several of Luye Pharma's key therapeutic areas.
Novartis
NVS
Mkt Cap297.32B
Novartis, offers a broad range of healthcare products that compete directly with Luye Pharma's portfolio, especially in the oncology and neurology sectors.
Pfizer
PFE
Mkt Cap161.09B
Pfizer, operates globally and has a strong presence in China, competing with Luye Pharma in areas like oncology, neurology, and other pharmaceutical sectors.
Merck
MRK
Mkt Cap298.84B
Merck & Co., known for its wide range of pharmaceutical products, competes in the oncology and vaccine markets where Luye Pharma is also active.
Bristol-Myers Squibb
BMY
Mkt Cap121.69B
Bristol-Myers Squibb, competes in the global oncology market, directly affecting Luye Pharma's business in similar therapeutic areas.

About

Luye Pharma Group Ltd., together with its subsidiaries, develops, produces, markets, and sells pharmaceutical products in the People's Republic of China, the United States, Europe, and internationally. The company offers Lipusu for ovarian cancer and carcinoma of ovary; CMNa, a chemical sensitizer for cancer radiotherapy; Boyounuo, an injection for the treatment of various types of cancers; and Xuezhikang, a lipid-regulating drug for the treatment of hypercholesterolaemia. It also provides Maitongna for cerebral edema swelling by trauma or surgery, and for venous reflux disorders; Beixi, an acarbose capsule for Type 2 diabetes; and Seroquel, Seroquel XR, Erzofri, Rivastigmine Multi-Day Transdermal Patch, and Rivastigmine. In addition, the company offers Rykindo, an injection for the treatment of schizophrenia; and Lutingnuo, a glutathione injection for toxicity and injuries caused by ionizing radiation. Further, it offers Oukai; Meibirui; Jinyouping; and other products. The company distributes and sells pharmaceutical drugs; research and development of antibody drugs; and manufactures and sells biopharmaceutical products. Luye Pharma Group Ltd. was founded in 1994 and is headquartered in Yantai, the People's Republic of China.
Show more...
CEO
Mr. Dian Bo Liu
Employees
5115
Country
Bermuda
ISIN
BMG570071099

Listings

STU
DE
LUP.STU
MU
DE
LUP.MU
F
DE
LUP.F
HK
HK
2186.HK

0 Comments

Share your thoughts

FAQ

What is Luye Pharma Group stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Luye Pharma Group stocks are traded under the ticker LUP.MU.
When is the next Luye Pharma Group earnings date?▼
Luye Pharma Group is going to release the next earnings report on August 27, 2026.
What were Luye Pharma Group earnings last quarter?▼
LUP.MU earnings for the last quarter are 0.01 EUR per share, whereas the estimation was 0.01 EUR resulting in a +0% surprise. The estimated earnings for the next quarter are N/A EUR per share.
How many employees does Luye Pharma Group have?▼
As of April 12, 2026, the company has 5,115 employees.
In which sector is Luye Pharma Group located?▼
Luye Pharma Group operates in the Health & Wellness sector.
When did Luye Pharma Group complete a stock split?▼
Luye Pharma Group has not had any recent stock splits.
Where is Luye Pharma Group headquartered?▼
Luye Pharma Group is headquartered in Yantai, Bermuda.